Učitavanje...
Temozolomide Nanoparticles for Targeted Glioblastoma Therapy
Glioblastoma (GBM) is a deadly and debilitating brain tumor with an abysmal prognosis. The standard therapy for GBM is surgery followed by radiation and chemotherapy with temozolomide (TMZ). Treatment of GBMs remains a challenge, largely due to the fast degradation of TMZ, inability to deliver an ef...
Spremljeno u:
| Izdano u: | ACS Appl Mater Interfaces |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4637162/ https://ncbi.nlm.nih.gov/pubmed/25751368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/am5092165 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|